AI platform provider Blackford and France-based medtech firm Pixyl are partnering to bring Pixyl.Neuro, an AI software for brain MRI analysis, to healthcare professionals via the Blackford Platform.
By integrating Pixyl’s technology into the Blackford Platform, Blackford can offer healthcare providers tools to support the diagnosis and monitoring of neuroinflammatory and neurodegenerative diseases on MRI. Pixyl.Neuro automatically analyzes brain MRI images to support rapid detection, early diagnosis, and objective monitoring of neurological disorders.
Pixyl.Neuro has received 510(k) class II clearance from the U.S. Food and Drug Administration (FDA), as well as the CE-mark class IIa certification in the European Union under the new medical device regulations.
